Drug Shortage Report for ELIGARD
Report ID | 204001 |
Drug Identification Number | 02248239 |
Brand name | ELIGARD |
Common or Proper name | Leuprolide acetate for injection |
Company Name | TOLMAR INTERNATIONAL LTD. |
Market Status | MARKETED |
Active Ingredient(s) | LEUPROLIDE ACETATE |
Strength(s) | 7.5MG |
Dosage form(s) | POWDER FOR SUSPENSION, SUSTAINED-RELEASE |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 Carton / Kit |
ATC code | L02AE |
ATC description | HORMONES AND RELATED AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-09-08 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2023-09-27 |
Shortage status | Resolved |
Updated date | 2023-09-28 |
Company comments | ELIGARD® 22.5 mg, 30 mg and 45 mg are available. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-844-986-5627 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-09-28 | English | Compare |
v8 | 2023-09-27 | French | Compare |
v7 | 2023-09-27 | English | Compare |
v6 | 2023-09-27 | English | Compare |
v5 | 2023-09-27 | English | Compare |
v4 | 2023-09-09 | English | Compare |
v3 | 2023-09-08 | French | Compare |
v2 | 2023-09-08 | English | Compare |
v1 | 2023-09-08 | English | Compare |
Showing 1 to 9 of 9